Description
D5.GSP医疗器械经营企业管理系统
1.GSP：在全国多省、市、区药监部门检查通过并得到认可检查通过;
2.进销存：采购管理、销售管理、备货管理、跟台管理；生产批号生命周期溯源；
3.财务：采购发票、销售发票、应收、应付、资产负债表、利润表、现金流量表
4.APP套件：查库存(公司库、医院库)、跟台订单、销售订单、跟台订单、跟台出库、申请采购、申请结算、申请发票、打卡、工作日志等
1.GSP：在全国多省、市、区药监部门检查通过并得到认可检查通过;
2.进销存：采购管理、销售管理、备货管理、跟台管理；生产批号生命周期溯源；
3.财务：采购发票、销售发票、应收、应付、资产负债表、利润表、现金流量表
4.APP套件：查库存(公司库、医院库)、跟台订单、销售订单、跟台订单、跟台出库、申请采购、申请结算、申请发票、打卡、工作日志等
Screenshots
D5.GSP医疗器械 FAQ
-
Is D5.GSP医疗器械 free?
Yes, D5.GSP医疗器械 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is D5.GSP医疗器械 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does D5.GSP医疗器械 cost?
D5.GSP医疗器械 is free.
-
What is D5.GSP医疗器械 revenue?
To get estimated revenue of D5.GSP医疗器械 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Colombia yet.
Ratings History
D5.GSP医疗器械 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
D5.GSP医疗器械 Installs
Last 30 days
D5.GSP医疗器械 Revenue
Last 30 daysD5.GSP医疗器械 Revenue and Downloads
Gain valuable insights into D5.GSP医疗器械 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
吉辉 丘
- Languages
- Recent release
- 2.1.9 (1 month ago )
- Released on
- Jul 20, 2022 (2 years ago )
- Also available in
- China , Romania , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , New Zealand , Peru , Philippines , Portugal , Japan , Russia , Sweden , Singapore , Thailand , Türkiye , Taiwan , United States , Vietnam , South Africa , Egypt , Azerbaijan , Belgium , Brazil , Belarus , Switzerland , Chile , Colombia , Czechia , Germany , Algeria , Australia , Spain , Finland , France , Greece , Hong Kong SAR China , Hungary , Israel , India , Italy
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.